Results
Revise Search
-
Filters:
- "BR2019-05" OR "PD19-02" OR "PD19-01" OR "BR2018-15" OR "BR2018-13" OR "BR2018-04" OR "PD18-01" OR "GC17-06" OR "BR2017-05" OR "BR2017-15" OR "GC16-30" OR "BR2016-04" OR "PD15-06" OR "BR2015-02" OR "GC14-55" OR "BR2014-12" OR "BR2014-04" OR "BR2014-03" OR "BR2014-02" OR "GC12-72"
- 2013
- 2016
- 2015
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
https://policybase.cma.ca/en/permalink/policy11035
- Date
- 2013-11-27
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Harms associated with opioids and other psychoactive prescription drugs
https://policybase.cma.ca/en/permalink/policy11535
- Date
- 2015-05-30
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/en/permalink/policy11847
- Date
- 2016-03-17
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Association. Policy Document PD15-06 - Harms associated with opioids and other
psychoactive prescriptions
1 document
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
https://policybase.cma.ca/en/permalink/policy13936
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
1 document
- Policy Type
- Parliamentary submission
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
Documents
